SMTL ID : 4bgg.3 (3 other biounits)

Crystal structure of the ACVR1 kinase in complex with LDN-213844

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.56 Å

Oligo State

monomer

Ligands

1 x 844: 1-{4-[5-(3,4,5-trimethoxyphenyl)pyridin-3-yl]phenyl}piperazine(Non-covalent)

844.1: 19 residues within 4Å: Chain A: V.16, V.24, A.35, V.36, K.37, E.50, L.65, L.83, T.85, H.86, Y.87, H.88, G.91, D.95, K.142, N.143, L.145, A.155, D.156 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.16, A:V.24, A:A.35, A:Y.87, A:L.145 Hydrogen bonds: A:H.88

1 x FLC: CITRATE ANION(Non-covalent)

FLC.2: 6 residues within 4Å: Chain A: H.86, Y.87, H.88, E.89, K.147, K.148 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:E.89, A:K.148 Water bridges: A:Y.87 Salt bridges: A:H.86, A:H.88, A:H.88, A:K.148

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mohedas, A.H. et al., Structure-Activity Relationship of 3,5-Diaryl-2-Aminopyridine Alk2 Inhibitors Reveals Unaltered Binding Affinity for Fibrodysplasia Ossificans Progressiva Causing Mutants. J.Med.Chem. (2014)

Release Date

2013-04-10

Peptides

ACTIVIN RECEPTOR TYPE-1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

ACTIVIN RECEPTOR TYPE-1

Related Entries With Identical Sequence